IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 241 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $270,266 | -29.7% | 33,699 | +29.9% | 0.01% | -44.4% |
| Q1 2024 | $384,549 | +250.9% | 25,948 | +92.5% | 0.01% | +800.0% |
| Q4 2023 | $109,576 | +81.3% | 13,478 | +1.5% | 0.00% | -50.0% |
| Q3 2023 | $60,442 | -26.9% | 13,284 | +13.2% | 0.00% | -33.3% |
| Q2 2023 | $82,629 | +108622.4% | 11,737 | -6.5% | 0.00% | +50.0% |
| Q1 2023 | $76 | -62.2% | 12,550 | -60.2% | 0.00% | -75.0% |
| Q4 2022 | $201 | -100.0% | 31,539 | -43.9% | 0.01% | -11.1% |
| Q3 2022 | $539,000 | +91.8% | 56,267 | +120.8% | 0.01% | +50.0% |
| Q2 2022 | $281,000 | +485.4% | 25,484 | +787.3% | 0.01% | – |
| Q1 2022 | $48,000 | +700.0% | 2,872 | +715.9% | 0.00% | – |
| Q4 2021 | $6,000 | -64.7% | 352 | -46.2% | 0.00% | – |
| Q3 2021 | $17,000 | -81.5% | 654 | -81.4% | 0.00% | -100.0% |
| Q2 2021 | $92,000 | -96.7% | 3,519 | -96.0% | 0.00% | -95.7% |
| Q1 2021 | $2,765,000 | +68.4% | 87,355 | +146.9% | 0.05% | -6.0% |
| Q4 2020 | $1,642,000 | +1257.0% | 35,380 | +862.7% | 0.05% | +4900.0% |
| Q3 2020 | $121,000 | -80.6% | 3,675 | -83.9% | 0.00% | -96.2% |
| Q2 2020 | $625,000 | +7712.5% | 22,778 | +8006.0% | 0.03% | +2500.0% |
| Q4 2019 | $8,000 | -92.9% | 281 | -95.4% | 0.00% | -87.5% |
| Q3 2019 | $112,000 | +286.2% | 6,157 | +413.1% | 0.01% | +300.0% |
| Q2 2019 | $29,000 | -70.7% | 1,200 | -86.4% | 0.00% | -71.4% |
| Q3 2018 | $99,000 | +518.8% | 8,842 | +625.3% | 0.01% | +600.0% |
| Q2 2018 | $16,000 | +1500.0% | 1,219 | +2157.4% | 0.00% | – |
| Q1 2018 | $1,000 | -80.0% | 54 | -92.0% | 0.00% | -100.0% |
| Q4 2017 | $5,000 | -93.0% | 672 | -92.7% | 0.00% | -83.3% |
| Q3 2017 | $71,000 | +3450.0% | 9,190 | +3193.9% | 0.01% | – |
| Q2 2017 | $2,000 | – | 279 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,019,201 | $26,720,000 | 20.38% |
| Broadfin Capital, LLC | 5,951,153 | $52,668,000 | 6.92% |
| GREAT POINT PARTNERS LLC | 5,567,348 | $49,271,000 | 6.23% |
| Avoro Capital Advisors LLC | 10,261,039 | $90,810,000 | 5.43% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $19,367,000 | 5.00% |
| Prosight Management, LP | 1,062,500 | $9,403,000 | 4.85% |
| Perceptive Advisors | 12,241,111 | $108,333,000 | 4.12% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,850,000 | 3.21% |
| QVT Financial LP | 1,021,361 | $8,696,000 | 2.84% |
| Vivo Capital, LLC | 1,600,000 | $14,160,000 | 1.81% |